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Summary
Background: Patients in opioid maintenance treatment might differ signi!cantly on major life events, coping resources 
and living conditions. Aim: This study investigated patients’ sociodemographic characteristics before !rst admission to 
opioid maintenance treatment, focusing on adverse experiences and their in"uence on age of opioid onset. Methods: 
Forty-seven participants were recruited from eight opioid maintenance treatment units in Bergen, Norway. Retrospective 
data on demographics, external potential adverse experiences and patients’ history of drug use were collected using the 
National Quality Register for Substance Abuse Treatment. A Cox regression survival analysis was conducted to exam-
ine potential differences in sociodemographic characteristics compared to age of opioid onset and adverse experiences. 
Results: The mean age of opioid onset was 22.6 years (SD = 6.80). No signi!cant differences between recruited patients 
were found for sociodemographic factors such as marital status, education level, living situation, parenthood and crime. 
Age of opioid onset use was strongly associated with being in care (b = 0.87), family members that were or had been in 
prison (b = 0.83) and drop-out from school (b = 0.77). The participants’ adverse experiences varied in number, with a 
mean exposure of 8.1 (SD = 4.0). Conclusions: Patients in this study had been exposed to many adverse experiences, yet 
these variated in both type and number. There was substantial variation in age of opioid onset. When new patients are en-
rolled in treatment, clinicians should consider this heterogeneity. It can be of importance in opioid maintenance treatment 
to distinguish between patients according to their number of adverse experiences. 
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1. Introduction
Opioid dependence is a chronic lifelong disease 
[8, 18, 20, 29, 44]. A well-documented effective treat-
ment for this disease is opioid maintenance treatment 
(OMT) [1, 8, 33]. A large body of research on OMT 
exists, including types of medication [39], physical 
and mental health [55, 68], the socioeconomic ben-
e!ts of treatment [11, 45, 65] and retention in OMT 
[57, 64]. Despite this, less is known about patients’ 
life events, coping resources and living conditions; 
these are factors that might differ signi!cantly. Such 
differences can be important in treatment planning 
and prognosis.
Previous studies on sociodemographic factors 
and OMT show a population that consists primarily 
of men in their thirties [16, 26, 43, 61, 70], with an 
education level of 11 to 12 years (SD = 2.2) [21, 31, 
41, 61, 62]. Some research shows that about half of 
the OMT population is unemployed [17, 21, 25, 43, 
60], while other studies report an employment rate 
from 67 to 81% [4, 8]. Research on living arrange-
ments for OMT populations is inconsistent. Some 
studies show that 40 to 60 % live with a partner [8, 
43, 46, 72], while others report 46 to 85% to be single 
or unmarried [18, 25, 40, 42]. Men are more likely to 
live alone [4, 72], while women are more likely to live 
with their children [72]. People with opioid depend-
ence become less involved in criminal activity after 
starting OMT [10, 11, 32, 65, 67]. 
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Kopak et al. [38] examined risks associated with 
demographic characteristics among substance use 
treatment patients. They found that  demographic risk 
factors, (e.g. age, marital status, employment and ed-
ucation) interact with clinical risks (i.e. substance use 
severity) and adolescent behavioural risks (e.g. school 
drop-out, arrests, shoplifting, several sexual partners), 
and increase the chance of relapse to substance use 
after treatment. According to Getz and Bray [23] the 
number of adverse experiences in a persons’ life had 
a greater impact on substance use than the number of 
protective factors. Risk factors can be understood as 
characteristics or hazards that increase the likelihood 
of a person developing a disorder [49]. Drug depend-
ence is often predicted by family history [22]. Poor 
family functioning increases the risk of developing 
early substance use and future heavy/problematic use 
[5, 30]. In general, cumulative risk factors in early 
childhood predict behaviour problems in adolescents 
[2, 22, 47]. The earlier the onset of opioid use, the 
greater the chance of problems later in life [50]. Fac-
tors related to the individual itself, school engage-
ment, and peers are also linked to adolescent problem 
behaviours [13]. In addition, there is a strong associa-
tion between childhood physical and/or sexual abuse 
and adult substance use [14, 24, 27]. Adverse experi-
ences tend to predict and correlate with substance use 
to a greater degree than protective factors [13, 36, 54]. 
Childhood and adolescence, the period that generally 
shapes the individual, is a myriad of different and 
unique stages that is important to investigate.
Age of onset is an essential adverse experience 
for, and a well-documented predictor of, alcohol de-
pendence and substance use disorder [6, 13, 35, 48, 
66]. However, age of opioid onset as an important 
factor has been less researched.
In referring to age of onset, research often dis-
tinguishes between early onset and late onset. Clark 
et al. [12] distinguished between adolescent (#17 
years), early-adult (18-24 years) and late adult (25 # 
years) onset groups with regard to substance use dis-
orders. Others have de!ned early onset as age < 18 
years and late onset as 18 years or older [3], or early 
onset as mean age 21 years and late onset as mean 
age 27 years [19]. Age of onset of opioid use varies 
from the early to late twenties [18, 25, 70], and Basu 
et al. [5] found that the early onset opioid group had a 
mean age of 18 years, while the late onset group had 
a mean age of 23 years.
Age of onset is signi!cantly associated with an 
increased risk of comorbidity [50], and when viewed 
as a background characteristic, age of opioid onset 
correlates with post-treatment substance use [38]. 
This shows that identifying potential adverse experi-
ences is central, as age of opioid onset is an important 
marker for the duration of substance use. In order to 
understand the life OMT patients have lived, it is vi-
tal to understand the background to the individual’s 
onset of opioid use. To the best of our knowledge, 
the current study is the !rst to focus on age of opioid 
onset and self-reported adverse experiences. 
Aim: We aimed to investigate a) the patients’ 
sociodemographic characteristics at !rst admission to 
opioid maintenance treatment, and b) how exposure 
to potential adverse experiences is associated with pa-
tients’ age of onset of opioid use. 
2. Methods
2.1. Design of the study
This longitudinal registry study was conducted 
at the Department of Addiction Medicine, Hauke-
land University Hospital, Bergen, Norway. Data was 
provided by the National Quality Register for Sub-
stance Abuse Treatment (NQR-SAT). NQR-SAT is a 
registry for treatment for harmful use or addiction to 
substance abuse, substance use disorders. This regis-
ter is structured around three main areas: basic regis-
tration, repeated data measures every third month in 
treatment, and at the end of treatment. In the current 
study data from basic registration are used, for more 
information see section about measures.
The inclusion criteria were: opioid dependence 
according to ICD-10 or DSM-IV [53], !rst-time ad-
mittances to OMT, living in the Haukeland Univer-
sity Hospital catchment area, and commencement 
of OMT medication before the !rst registration. The 
only exclusion criterion was lack of competence to 
consent.
The sample was recruited from eight OMT out-
patient units within the catchment area of Haukeland 
University Hospital; one unit was located in the prison 
in Bergen County. Due to low recruitment in the !rst 
year of the study, eligible participants were enrolled 
in OMT in two periods. The !rst recruitment period 
was from January to December 2013, and the second 
period was from September 2015 to June 2016.
2.2. Sample
Fourth-eight opioid-dependent persons partici-
pated in our study, 11 women and 37 men. Twenty-
three participants were recruited in the !rst period 
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and 25 in the second period. One participant with-
drew due to lack of interest and these data are not 
included in the analysis, leaving a total sample of 47 
participants. 
2.3. Instruments
Data collected by NQR-SAT was based on Pa-
tient Reported Outcome Measures (PROM-data) and 
Patient Reported Experience Measure (PREM-data). 
PROMs include patients’ reports of health, experienc-
es during treatment and the impact of the treatment 
on their quality of life [7, 51, 63]. PREMs capture 
patients’ perceptions of their experience with health 
care or treatment [63]. The NQR-SAT contains sever-
al items such as sociodemographic status, life events, 
drug history, mental and physical health, quality of 
life and participants’ actions for reducing their drug 
problems. In the current article, background data on 
sociodemographic status, life history, and drug his-
tory are used. These topics include various sub-ques-
tions.
Sociodemographic status: Eleven questions 
measured the respondents’ sociodemographic status 
such as: age, education level, living arrangements, 
children and criminality, see Table 1.
Negative life events: Twenty-one questions were 
related to negative life events, and covered domains 
such as family (e.g. addiction, !nancial dif!culties, 
jail, mental issues, long-lasting somatic disease, di-
vorce and neglect), and community (e.g., drop-out, 
break-ups, dismissal, housing, and being under care). 
In order to measure whether participants had or had 
none adverse experiences the answers were dichoto-
mized as yes or no. Seventeen of these 21 negative 
life events were included in the analysis.
Drug history: Seventeen questions covered his-
tory of drug use. Age or year of onset was self-re-
ported. Participants reported abuse of up to 18 spe-
ci!c substances from onset to enrolment in OMT. 
Frequency was measured by six categories: daily use, 
5-6 times a week, 2-4 times a week, weekly, periodi-
cally or seldom. Route of administration was a di-
chotomous variable measured by yes or no to injected 
substance abuse. The reasons for onset of drug use 
were categorized into: curiosity, in"uenced of others, 
by coincidence, having one’s own problems or other 
reasons. The main reasons for substance abuse were 
mutually exclusive and categorized into: medical, so-
cial, coercion, getting high or other reasons.
2.4. Procedure
In 2013, the local OMT advisors informed new-
ly enrolled patients about the study. Also, a letter with 
study information and an invitation to participate was 
sent to all !rst time enrolled patients. In 2015/2016, 
unit managers in OMT informed their employees 
about the study, ensured that information lea"ets were 
visible at all OMT units, and contacted the research 
unit when new patients were enrolled. Furthermore, a 
study researcher was present in the waiting rooms in 
the OMT units. All patients interested in participat-
ing, or in need of more information were contacted 
by phone, SMS or face-to face of a researcher by the 
research unit.
Written informed consent was obtained from 
participants who agreed to join the study. Data were 
collected as structured registrations through face-to-
face interviews. A researcher from the research unit 
was responsible for recruitment, registration, call-
ing in the participants and data management. The 
study was approved by the Regional Committee for 
Medical and Health Research Ethics (2013/429/REK 
south-east C).
2.5. Data analysis
In order to get a better understanding of partici-
pants' life cycle until enrollment in OMT, it is impor-
tant to study crossroads and events in the participants’ 
life. This was the reason why a survival analysis was 
chosen as the statistical approach. 
Descriptive statistics were used to examine the 
participants’ demographic characteristics. A survival 
analysis was conducted using Cox regression to ex-
amine if there were signi!cant differences in sociode-
mographic characteristics, compared to age of opioid 
onset (heroin, methadone, buprenorphine, and other 
opioids) and potential adverse experiences. For the 
results to be reliable, the number of events must be 
higher than 10 events per investigated variable [56, 
73]. In the current study a total of 1026 observations 
were available in the data analysis. A con!dence in-
terval of 95% was set.
Age of opioid onset was the dependent variable. 
Included as independent variables seventeen adverse 
childhood/adolescents experiences were included in 
the analysis. 
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3. Results
Descriptive variables of the participants’ charac-
teristics are shown in Table 1. The mean age was 37.8 
years, ranging from 23 to 61 years (SD = 8.58). With 
regard to education level, none of the female partici-
pants had higher education than high school, while 
nine of 36 men had a certi!cate of apprenticeship or 
had studied at university. Half of the participants lived 
in their own apartment, and among these 79 % were 
40 years or older. Participants younger than 40 years 
had mainly temporary living arrangements. Seven 
of 11 females and half of the male participants had 
children; however, a minority had custody or visita-
tion rights. More than 63% had no legal problem or 
contact with the justice system the previous months 
before OMT enrolment.
The mean age for substance use onset was 14.3 
years (SD = 4.87). Sixty-two percent started with al-
cohol and 23.4 % with cannabis. At age sixteen, 89 % 
had used a substance. Curiosity was the main reason 
for onset for 55 % of the participants, while being in-
"uenced by others (21.3%) and chances (15%) were 
other reasons for substance use debut. The mean age 
of opioid onset was 22.6 years, ranging from 14 to 
43 years (SD = 6.80). Over 60 % of participants used 
opioids (heroin, methadone, buprenorphine or other 
opioids) on a daily basis before enrolling in OMT. 
The main reason given for opioid use was a medical 
purpose to regulate emotions.
Exposure for adverse experiences differed 
among participants. Adverse experiences such as con-
"ict with the justice system/police and loss of family 
members or other close ones by death were highly 
frequent (see Table 2), while working as a sex worker 
or experience suicide in the family were infrequent 
adverse experiences. More than half of the partici-
pants had been exposed to at least eight adverse expe-
riences, see Table 2. When a Bonferroni adjusted al-
pha level of .002 was used, there were no statistically 
signi!cant observed differences between participants 
from the two periods.
A survival analysis by Cox regression revealed 
a statistically signi!cant association between adverse 
Table 1. Baseline sociodemographic characteristics for 
!rst time enrolees in opioid maintenance treatment
Type of risk exposure N = 47 %
Gender, Male 36 76.6
Age, M 37.8
Age of onset opioid use a 22





No education 4 8.5
Primary/secondary school 21 44.7
High school 13 27.7
Higher education 9 19.1
Living situation
Own apartment 24 51.1
Permanently with family 7 14.9
Temporary living arrangementb 14 29.8
Homeless 2 4.3
Children
Parenthood, yes 25 53.2
Custody of children <18 years 4 8.5
Visitation rights children <18 
years 14 29.7
No custody/visitation rights 4 8.5
Adult children 7 14.9
Criminality
Waiting to serve a sentence, 
Yes 5 10.6
Unresolved issues with the 
police/justice system, Yes 17 36.2
Note. aMissing data for three participants. bTemporay living 
arrangements = prisons, rehabilitation homes and treatment 
institutions.
Table 2. Number of patients exposed to adverse experi-
ences
Type of adverse experiences n %
Loss of family members/other close 
ones (deaths) 42 89.3
Con"ict with the justice system/police 38 80.8
Drug (ab-)use in the family 27 57.4
Drop out from school 27 57.4
Mental issues in the family 26 55.3
Caregivers (parents) separation 26 55.3
Had been beaten 26 55.3
Protracted physical illness in the family 24 51.0
Had been bullied 22 46.8
Neglected over time 22 46.8
Sexually violated 21 44.6
Negative relationship with partner 20 42.5
Family members in prison 18 38.2
Financial problems for caregivers 17 36.1
Being in care 11 23.4
Suicide in the family 9 19.9
Sex work 7 14.8
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4. Discussion
The present study investigated the sociodemo-
graphic factors and the relationship between potential 
adverse experiences and age of onset of opioid use 
for !rst-time admittances to OMT. Our main !nding 
was that OMT patients differed in their exposure to 
adverse events. These differences in exposure were 
systematically associated with differences in age of 
opioid use onset [18, 69, 70]. Education level is a year 
or two less than in other studies [21, 31, 65]. Norwe-
gian research shows that 69 % of OMT patients have 
learning- and behaviour problems in primary school 
[40], which may explain the variation in education 
level. 
Research has shown that the number of risk fac-
tors, individuals must cope with, is more important 
than the type of applicable risks [9, 52]. Our study 
did not include exact information about the timing of 
adverse experiences. However, due to the diversity 
of examined adverse experiences and that these are 
strongly related to family relationships, it is reasona-
ble to assume that may have occurred in participants’ 
childhood or adolescence, and thereby before opioid 
age of onset. 
Cumulative adverse experiences may explain the 
high number of adverse experiences [2, 22]; the early-
onset users had been exposed to a higher number of 
potential adverse experiences compared to the late-
onset opioid users. It seems like the early-onset users 
have a lower level of protection against new potential 
experiences and age of onset of opioid. There were 
no statistically signi!cant association for three ad-
verse experiences and age at opioid onset (Table 3). 
A strong association to age of opioid onset use was 
identi!ed for being in care (b = 0.87), family mem-
bers that were or had been in prison (b = 0.83) and 
drop-out from school (b = 0.77). Family relations 
were systematically linked to age at opioid onset. 
Family members in prison, caregivers with !nancial 
issues, drug abuse or suicide in the family all had a 
substantial association with age of opioid onset, un-
like severe somatic disease or mental issues in close 
family members. There was a stronger association be-
tween sex work and age of opioid onset than traumas 
such as having been beaten or bullied.  
The number of adverse experiences participants 
had been exposed to varied signi!cantly. The mean 
exposure was 8.1 (SD = 4.0). Based on the total num-
ber of adverse experiences, three groups were con-
structed: a low risk group exposed to zero to !ve ad-
verse experiences, a medium risk group exposed to 
six to 11 adverse experiences, and a high risk group 
exposed to 12 to 17 adverse experiences. Fifty-nine 
percent had a medium risk exposure, while belong-
ing to the high risk group, reported by 17.4 %, was 
associated with lower age of opioid onset, as shown 
in Figure 1.  
Table 3. Exposure to adverse experiences before enrolment in OMT and age of onset of opioid use
Adverse experiences B SE p Exp B 95 % CI
Being in care 0.87 0.09 <.001* 2.40 1.98 2.91
Family members in prison 0.83 0.08 <.001* 2.30 1.95 2.72
Drop-out from school 0.77 0.08 <.001* 2.16 1.84 2.54
Financial problems for caregivers 0.71 0.09 <.001* 2.04 1.71 2.43
Sex work 0.69 0.10 <.001* 1.99 1.62 2.45
Drug abuse in the family 0.64 0.08 <.001* 1.90 1.62 2.23
Suicide in the family 0.61 0.09 <.001* 1.85 1.52 2.24
Caregivers (parents) separation 0.61 0.08 <.001* 1.84 1.56 2.17
Sexually violated 0.56 0.08 <.001* 1.75 1.50 2.05
Mental issues in the family 0.48 0.08 <.001* 1.62 1.38 1.91
Protracted physical illness in the family 0.48 0.08 <.001* 1.61 1.38 1.89
Con"ict with the justice system/police 0.45 0.10 <.001* 1.58 1.28 1.94
Had been bullied 0.37 0.08 <.001* 1.45 1.24 1.69
Had been beaten 0.21 0.08 .009 1.23 1.05 1.44
Neglected over time 0.03 0.08 .680 1.03 0.88 1.21
Loss of family members/other close ones -0.01 0.13 .913 0.98 0.75 1.28
Negative relationship with partner -0.03 0.08 .636 0.96 0.82 1.12
Note. CI = con!dence interval;*P <.002
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socializing agent when it comes to societal norms and 
prohibitions. Drop-outs from school tend to seek for 
companionship with like-minded peers, and this pro-
vides an entrance into environment where other rules 
apply compared to the socially accepted norms. With 
regard to school drop-out, Kolar et al. [37] reported 
that 41% of children of OMT patients were truant, 
and 30% had been suspended from school.
Family-related factors are predictors with a 
strong in"uence on a patient’s life. Multiple risks in 
early childhood explain differences in predicting ado-
lescent behaviour outcomes [2]. According to Lau-
ritzen et al. [40], 54 % of OMT patients have parents 
with mental issues and 57 % have parents with alcohol 
problems. Our study showed that adverse experiences 
such as family members in prison, !nancial problems 
for caregivers and drug abuse in the family had a sig-
ni!cant effect on age of opioid onset. It is interest-
ing to note, that despite of the small sample, being in 
care is signi!cantly associated with age of opioid on-
set. School drop-out, being in care and troublesome 
family relations can be indicators of non-supportive 
homes. These results can indicate that OMT patients 
in the current study often had a stressful family situa-
tion, and support from parents was more or less lack-
ing which has a negative effect on their development 
into adults. Adolescents from such homes may be 
more likely to engage with deviant peers to gain so-
cial support and a sense of belonging [30].
adverse experiences, which add to the total number of 
adverse experiences they have to manage. On the oth-
er hand, the late-onset opioid users may have a higher 
protection against or awareness of potential adverse 
experiences. They might live in low-risk environment 
where new adverse experiences are more distinct to 
earlier life experiences. This study has not taken into 
consideration that there might be different protective 
factors for the late-onset and early-onset users. Based 
on the systematic connection between adverse experi-
ences and age of opioid onset, the late-onset individu-
als, compared to the early-onset individuals, bring 
other life experiences with them into treatment from 
e.g. school, family life or work. Timing of opioid on-
set is therefore signi!cant.    
Moreover, unlike Bry et al. [9] our study showed 
that the type of adverse experiences was indeed im-
portant for the participants. School drop-out was a 
high frequent experience, 27 of 47 participants re-
ported school drop-out, and a strong predictor for age 
of opioid onset; the younger the age at opioid onset, 
the greater the probability of school drop-out. The 
link between alcohol/drug abuse and school drop-out 
is well documented [15, 34, 71], and the negative ef-
fect has recently been con!rmed by Heradstveit et al. 
[28]. They found that an increasing number of alco-
hol/drug related problems and levels of consumption 
were associated with negative school-related out-
comes. During adolescence, school is an important 
)LJXUH$JHRIRSLRLGRQVHWDQGQXPEHURIDGYHUVHH[SHULHQFHV
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Figure 1 Age of opioid onset and number of adverse experiences
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implication of this study is that clinical work should 
distinguish between patients who have been exposed 
to few versus many adverse experiences. If clinicians 
closely examined patients’ background and adverse 
experiences at !rst time enrolment, they could indi-
cate and facilitate a treatment with a more individual 
approach to a greater extent than today. That would 
be of bene!t both for patients and clinic. 
5. Conclusions
There is a substantial variation related to soci-
odemographic characteristics and adverse experi-
ences for participants in this study.  This heteroge-
neity ought to be taken into consideration when new 
patients are enrolled in OMT. This study shows that 
both type and the number of adverse experiences can 
be associated to age of opioid onset. Although the re-
sults cannot be generalized to the OMT population 
per se, it can important for treatment to distinguish 
between people enrolled in OMT with few versus 
several adverse experiences.
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